ImmunityBio, Inc. (IBRX)

ImmunityBio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	-	88.33	143.43	265.45	104.64	181.1
Short-Term Investments	175.69	154.48	6.38	1.01	2.54	136.02
Cash & Short-Term Investments	175.69	242.82	149.81	266.46	107.18	317.12
Cash Growth	185.25%	62.09%	-43.78%	148.60%	-66.20%	230.12%
Accounts Receivable	-	42.57	2.36	-	-	-
Other Receivables	0	0.05	0.29	2.02	1.89	1.33
Total Trade Receivables	0	42.62	2.65	2.02	1.89	1.33
Inventory	0.55	0.91	8.27	-	-	-
Other Current Assets	2.07	28.53	23.85	25.6	31.5	15.9
Total Current Assets	178.31	314.88	184.59	294.08	140.58	334.35
Net Property, Plant & Equipment	33.03	147.27	170.46	182.63	189.45	119.17
Other Intangible Assets	-	-	-	-	20	1.42
Goodwill	12.89	13.95	15.93	17.09	-	-
Long-Term Investments	-	7.38	7.13	7.77	7.47	7.2
Other Long-Term Assets	19.23	18.42	4.83	2.88	4.86	6.78
Total Assets	243.46	501.9	382.93	504.45	362.36	468.91
Accounts Payable	11.19	6.98	6.73	9.2	21.02	11.42
Accrued Expenses	48.2	46.84	40.58	42.71	41.83	51.39
Short-Term Debt	-	-	-	-	431.9	299.24
Current Portion of Leases	7.63	7.54	7.47	5.24	2.65	3.01
Other Current Liabilities	0.93	0.4	0.17	1.14	3.47	3.94
Total Current Liabilities	67.95	61.75	54.94	58.28	500.86	369
Long-Term Debt	1,083	801.71	746.28	836.95	241.27	306.35
Long-Term Leases	33.15	33.45	34.82	39.94	47.95	37.07
Other Long-Term Liabilities	331.98	104.56	35.01	155.21	22.09	0.41
Total Long-Term Liabilities	1,448	939.72	816.12	1,032	311.32	343.83
Total Liabilities	1,516	1,001	871.06	1,090	812.18	712.82
Common Stock	0.1	0.1	0.09	0.07	0.04	0.04
Additional Paid-in Capital	3,462	3,197	2,885	2,375	1,931	1,720
Accumulated Other Comprehensive Income	27.45	28.96	1.2	0.01	0.18	0
Retained Earnings	-4,359	-3,727	-3,375	-2,962	-2,378	-1,962
Total Common Shareholders' Equity	-870.01	-500.47	-489.1	-586.99	-447.33	-242.17
Minority Interest	0.88	0.9	0.97	1.05	-2.49	-1.74
Shareholders' Equity	-869.13	-499.57	-488.13	-585.94	-449.82	-243.91
Total Liabilities & Equity	646.64	501.9	382.93	504.45	362.36	468.91
Total Debt	1,123	842.69	788.57	882.14	723.77	645.66
Net Cash (Debt)	-947.77	-599.87	-638.76	-615.68	-616.59	-328.55
Net Cash Per Share	-1.00	-0.65	-0.91	-1.21	-1.54	-0.84
Book Value	-870.01	-500.47	-489.1	-586.99	-447.33	-242.17
Book Value Per Share	-0.92	-0.54	-0.70	-1.15	-1.12	-0.62
Tangible Book Value	-882.89	-514.42	-505.03	-604.08	-467.33	-243.59
Tangible Book Value Per Share	-0.93	-0.56	-0.72	-1.19	-1.17	-0.63

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q